Latest Ochre Bio News & Updates

See the latest news and media coverage for Ochre. We track all announcements, press releases, and industry mentions in real time, all in one place.

Ochre Bio (Ochre)

Human-data-driven liver therapeutics developer

ochre-bio.com

Headquarters: Oxford, United Kingdom
Founded year: 2019
Company type: Private company
Number of employees: 50–59
Industry: Pharmaceuticals

Last updated March 28

Latest news about Ochre Bio (Ochre)

In short: Ochre raised $30M, signed GSK and Boehringer Ingelheim deals, and launched a Liver ICU in New York.

Company announcements

January 9 Ochre

Ochre appoints Sarah Batey as COO

Sarah brings over 15 years of experience in advancing therapies. She will lead operations across Oxford, New York, and Taipei teams.

January 6 Ochre

Ochre CEO and CBO attend J.P. Morgan Healthcare Conference

Quin Wills and Jack Castle head to San Francisco next week to meet investors, collaborators, and partners. Interested parties can reach out to them.

December 18, 2025 Ochre

Ochre opens new liver ICU in New York City

The site features a large ex-vivo machine perfusion lab for late-stage validation and clinical trials. It honors team, partners, and organ donors.

December 17, 2025 Ochre

Ochre develops world's first Organ ICU

The platform tests drug candidates in intact human livers under near-physiological conditions in their New York lab. It bridges validation and therapies.

Media coverage

March 28 Business Wire

Ochre Bio Raises $30M Series A Financing for the Development of RNA Therapies for Chronic Liver Diseases

Proceeds to support the development of first candidates for IND-enabling studies, as well as expand discovery and RNA chemistry capabilities to address a wider set...

October 21, 2025 New York Post

This company aims to end the need for liver transplants — as thousands die every year on the waitlist

Over 11,000 liver transplants were performed last year in the US, while thousands more patients remained in limbo.

October 20, 2025 KXAN

New NYC 'Liver ICU' Lab Transforming Liver Disease Treatments

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has opened a unique perfusion 'Liver...

July 16, 2025 Commercial Observer

Liver Disease Researcher Ochre Bio Signs 6K-SF Lease at Biotech Center

Ochre Bio leased 5,894 square feet at Alexandria Real Estate Equities' Alexandria Center for Life Science at 430 East 29th Street.

Never miss news about Ochre

Track Ochre and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ochre competitors & trending companies

Browse news for competitors to Ochre and other trending companies.